Drug-induced arrhythmia: pharmacogenomic prescribing?
Open Access
- 22 October 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (2), 89-95
- https://doi.org/10.1093/eurheartj/ehs351
Abstract
Drug-induced Torsades de Pointes is a rare, unpredictable, and life-threatening serious adverse event. It can be caused by both cardiac and non-cardiac drugs and has become a major issue in novel drug development and for the regulatory authorities. This review describes the problem, predisposing factors, and the underlying genetic predisposition as it is understood currently. The future potential for pharmacogenomic-guided and personalized prescription to prevent drug-induced Torsades de Pointes is discussed. Database searches utilized reports from www.qtdrugs.org up to January 2012, case reports and articles from www.pubmed.com up to January 2012, and the British National Formulary edition at www.bnf.org.Keywords
This publication has 68 references indexed in Scilit:
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT ProjectClinical Pharmacology & Therapeutics, 2012
- Suppression of Phosphoinositide 3-Kinase Signaling and Alteration of Multiple Ion Currents in Drug-Induced Long QT SyndromeScience Translational Medicine, 2012
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in EuropeansThe New England Journal of Medicine, 2011
- Common variants at ten loci influence QT interval duration in the QTGEN StudyNature Genetics, 2009
- Common variants at ten loci modulate the QT interval duration in the QTSCD StudyNature Genetics, 2009
- Case ascertainment and estimated incidence of drug‐induced long‐QT syndrome: study in Southwest FranceBritish Journal of Clinical Pharmacology, 2008
- CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heartProceedings of the National Academy of Sciences of the United States of America, 2008
- HLA-B*5701 Screening for Hypersensitivity to AbacavirThe New England Journal of Medicine, 2008
- A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarizationNature Genetics, 2006
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionThe New England Journal of Medicine, 1999